Literature DB >> 27868006

Circulating fibrocytes serve as a marker for clinical diagnosis.

Thuy Cao1, Sheeja Rajasingh1, Johnson Rajasingh2.   

Abstract

Year:  2016        PMID: 27868006      PMCID: PMC5104631          DOI: 10.21037/atm.2016.10.26

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


× No keyword cloud information.
  18 in total

1.  Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2016-01-26       Impact factor: 29.690

2.  Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction.

Authors:  M J van Amerongen; G Bou-Gharios; Er Popa; J van Ark; A H Petersen; G M van Dam; M J A van Luyn; M C Harmsen
Journal:  J Pathol       Date:  2008-02       Impact factor: 7.996

Review 3.  The role of circulating fibrocytes in fibrosis.

Authors:  Timothy E Quan; Shawn E Cowper; Richard Bucala
Journal:  Curr Rheumatol Rep       Date:  2006-04       Impact factor: 4.592

4.  Differentiation of circulating monocytes into fibroblast-like cells.

Authors:  Darrell Pilling; Richard H Gomer
Journal:  Methods Mol Biol       Date:  2012

5.  Bone marrow-derived cells contribute to fibrosis in the chronically failing heart.

Authors:  Po-Yin Chu; Justin Mariani; Samara Finch; Julie R McMullen; Junichi Sadoshima; Tanneale Marshall; David M Kaye
Journal:  Am J Pathol       Date:  2010-02-11       Impact factor: 4.307

6.  Fibrocytes: emerging effector cells in chronic inflammation.

Authors:  Ronald A Reilkoff; Richard Bucala; Erica L Herzog
Journal:  Nat Rev Immunol       Date:  2011-05-20       Impact factor: 53.106

7.  Alternative strategies to manipulate fibrocyte involvement in the fibrotic tissue response: pharmacokinetic inhibition and the feasibility of directed-adipogenic differentiation.

Authors:  David W Baker; Yi-Ting Tsai; Hong Weng; Liping Tang
Journal:  Acta Biomater       Date:  2014-03-18       Impact factor: 8.947

8.  Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes.

Authors:  Sarah M Williams; Lucy Golden-Mason; Bradley S Ferguson; Katherine B Schuetze; Maria A Cavasin; Kim Demos-Davies; Michael E Yeager; Kurt R Stenmark; Timothy A McKinsey
Journal:  J Mol Cell Cardiol       Date:  2013-12-26       Impact factor: 5.000

Review 9.  Role of Circulating Fibrocytes in Cardiac Fibrosis.

Authors:  Rong-Jie Lin; Zi-Zhuo Su; Shu-Min Liang; Yu-Yang Chen; Xiao-Rong Shu; Ru-Qiong Nie; Jing-Feng Wang; Shuang-Lun Xie
Journal:  Chin Med J (Engl)       Date:  2016-02-05       Impact factor: 2.628

10.  Rapid detection of circulating fibrocytes by flowcytometry in idiopathic pulmonary fibrosis.

Authors:  Esam H Alhamad; Zahid Shakoor; Feisal A Al-Kassimi; Adel Almogren; Mohamed O Gad ElRab; Shyam Maharaj; Martin Kolb
Journal:  Ann Thorac Med       Date:  2015 Oct-Dec       Impact factor: 2.219

View more
  2 in total

Review 1.  The Blood Circulating Rare Cell Population. What is it and What is it Good For?

Authors:  Stefan Schreier; Wannapong Triampo
Journal:  Cells       Date:  2020-03-25       Impact factor: 6.600

2.  Stromal CCL2 Signaling Promotes Mammary Tumor Fibrosis through Recruitment of Myeloid-Lineage Cells.

Authors:  Genevra Kuziel; Victoria Thompson; Joseph V D'Amato; Lisa M Arendt
Journal:  Cancers (Basel)       Date:  2020-07-28       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.